Next‐generation sequencing approaches and challenges in the diagnosis of developmental anomalies and intellectual disability

Recent advances in next‐generation sequencing (NGS) technologies have revolutionized the field of human genetics. Alongside a broad panel of bioinformatics tools and databases, NGS technologies have unprecedentedly improved the molecular diagnosis rate and the identification of new genes associated with rare disorders. However, about 50% of patients remain without a final diagnosis. Here, we highlight the utility of NGS applications in developmental anomalies and intellectual disability, illustrating their main advantages and pitfalls. Through specific examples, we suggest novel strategies and tools for identifying the molecular bases in the remaining patients, and we outline future challenges.

[1]  David J Balding,et al.  Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation , 2017, Genome research.

[2]  F. Real,et al.  Many mosaic mutations. , 2013, Current oncology.

[3]  J. Rivière,et al.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.

[4]  M. Ergun,et al.  A new method for analysis of whole exome sequencing data (SELIM) depending on variant prioritization , 2017 .

[5]  M. Marra,et al.  Comprehensive whole genome sequence analyses yields novel genetic and structural insights for Intellectual Disability , 2017, BMC Genomics.

[6]  A. Ekici,et al.  Exome Pool-Seq in neurodevelopmental disorders , 2017, European Journal of Human Genetics.

[7]  A. Magi,et al.  Detection of Genomic Structural Variants from Next-Generation Sequencing Data , 2015, Front. Bioeng. Biotechnol..

[8]  R. Myers,et al.  Systematic reanalysis of genomic data improves quality of variant interpretation , 2018, Clinical genetics.

[9]  J. Stockman,et al.  A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome , 2013 .

[10]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[11]  G. Bejerano,et al.  Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers , 2016, Genetics in Medicine.

[12]  Patrick J. Short,et al.  Contribution of retrotransposition to developmental disorders , 2018, Nature Communications.

[13]  Patrick Callier,et al.  Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis , 2017, Genetics in Medicine.

[14]  Véronique Geoffroy,et al.  Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing , 2014, Journal of Medical Genetics.

[15]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[16]  Alessandra Renieri,et al.  Targeted Next‐Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability , 2015, Human mutation.

[17]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[18]  Francesco Muntoni,et al.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2016, Science Translational Medicine.

[19]  J. Carpten,et al.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.

[20]  Serafim Batzoglou,et al.  Genome assembly from synthetic long read clouds , 2016, Bioinform..

[21]  S. Cheung,et al.  BAFopathies’ DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin–Siris and Nicolaides–Baraitser syndromes , 2018, Nature Communications.

[22]  Jing Zhao,et al.  A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood. , 2016, American journal of human genetics.

[23]  A. Need,et al.  The importance of dynamic re-analysis in diagnostic whole exome sequencing , 2016, Journal of Medical Genetics.

[24]  J. Schuurs-Hoeijmakers,et al.  A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. , 2018, American journal of human genetics.

[25]  Thomas Meitinger,et al.  Genetic diagnosis of Mendelian disorders via RNA sequencing , 2017, Nature Communications.

[26]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[27]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[28]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[29]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[30]  Roberta A Pagon,et al.  GeneTests: an online genetic information resource for health care providers. , 2006, Journal of the Medical Library Association : JMLA.

[31]  G. Mancini,et al.  De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes. , 2019, Human molecular genetics.

[32]  L. Vissers,et al.  Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.

[33]  Barbara Plecko,et al.  Multiomics tools for the diagnosis and treatment of rare neurological disease , 2018, Journal of Inherited Metabolic Disease.

[34]  I. Katona,et al.  Frequent genes in rare diseases: panel‐based next generation sequencing to disclose causal mutations in hereditary neuropathies , 2017, Journal of neurochemistry.

[35]  S. Scherer,et al.  Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing , 2018, European Journal of Human Genetics.

[36]  D. Valle,et al.  GeneMatcher Aids in the Identification of a New Malformation Syndrome with Intellectual Disability, Unique Facial Dysmorphisms, and Skeletal and Connective Tissue Abnormalities Caused by De Novo Variants in HNRNPK , 2015, Human mutation.

[37]  Tudor Groza,et al.  Matchmaker Exchange , 2017, Current protocols in human genetics.

[38]  G. Barsh,et al.  Genomic diagnosis for children with intellectual disability and/or developmental delay , 2017, Genome Medicine.

[39]  Tomas W. Fitzgerald,et al.  Detection of structural mosaicism from targeted and whole-genome sequencing data , 2016, bioRxiv.

[40]  M. V. van Steensel.  Neurocutaneous Manifestations of Genetic Mosaicism , 2015, Journal of Pediatric Genetics.

[41]  A. Goris,et al.  Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis , 2012, Human molecular genetics.

[42]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[43]  V. Jobanputra,et al.  Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma. , 2018, Methods in molecular biology.

[44]  M. Zacchia,et al.  Integration of Proteomics and Metabolomics in Exploring Genetic and Rare Metabolic Diseases , 2017, Kidney Diseases.

[45]  Julia Wynn,et al.  The usefulness of whole-exome sequencing in routine clinical practice , 2014, Genetics in Medicine.

[46]  L. Vissers,et al.  Identification of rare de novo epigenetic variations in congenital disorders , 2018, bioRxiv.

[47]  Gong-Hong Wei,et al.  Enhancer Dysfunction in 3D Genome and Disease , 2019, Cells.

[48]  M. Roselló,et al.  High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing , 2016, Journal of Medical Genetics.

[49]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[50]  C. Francks,et al.  Next-gen sequencing identifies non-coding variation disrupting miRNA-binding sites in neurological disorders , 2017, Molecular Psychiatry.

[51]  B. Fernandez,et al.  Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care , 2015, Clinical genetics.

[52]  W. Bush,et al.  Comprehensive Analysis of Constraint on the Spatial Distribution of Missense Variants in Human Protein Structures. , 2018, American journal of human genetics.

[53]  2.5 years’ experience of GeneMatcher data-sharing: a powerful tool for identifying new genes responsible for rare diseases , 2018, Genetics in Medicine.

[54]  Michael Brudno,et al.  PhenomeCentral: A Portal for Phenotypic and Genotypic Matchmaking of Patients with Rare Genetic Diseases , 2015, Human mutation.

[55]  M. Alfadhel,et al.  Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing , 2018, Genetics in Medicine.

[56]  Donald G Basel,et al.  A Review of Next‐Generation Genetic Testing for the Dermatologist , 2013, Pediatric dermatology.

[57]  Stefan Mundlos,et al.  Looking beyond the genes: the role of non-coding variants in human disease. , 2016, Human molecular genetics.

[58]  Daniele Merico,et al.  Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test , 2017, Genetics in Medicine.

[59]  H. Prokisch,et al.  “Transcriptomics”: molecular diagnosis of inborn errors of metabolism via RNA-sequencing , 2018, Journal of Inherited Metabolic Disease.

[60]  Rémy Bruggmann,et al.  Clinical sequencing: is WGS the better WES? , 2016, Human Genetics.

[61]  F. Alkuraya,et al.  The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes , 2017, Human Genetics.

[62]  John Hardy,et al.  Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences , 2016, Briefings Bioinform..

[63]  Yiping Shen,et al.  Experimental Tools for the Identification of Specific Genes in Autism Spectrum Disorders and Intellectual Disability , 2016 .

[64]  Michael Brudno,et al.  Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine , 2016, npj Genomic Medicine.

[65]  Shekhar Saxena,et al.  Prevalence of intellectual disability: a meta-analysis of population-based studies. , 2011, Research in developmental disabilities.

[66]  T. Kleefstra,et al.  [Genetic diagnostics in intellectual disability: what is the benefit?]. , 2014, Nederlandsch tijdschrift voor geneeskunde.

[67]  J. Rivière,et al.  Mosaicism for a KITLG Mutation in Linear and Whorled Nevoid Hypermelanosis. , 2017, The Journal of investigative dermatology.

[68]  Kevin S. Smith,et al.  High-Resolution Transcriptome Analysis with Long-Read RNA Sequencing , 2014, PloS one.

[69]  Martin O Pollard,et al.  Long reads: their purpose and place , 2018, Human molecular genetics.

[70]  Marcel E Dinger,et al.  Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders , 2018, Genetics in Medicine.

[71]  Alejandro Sifrim,et al.  Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.

[72]  D. Srivastava,et al.  microRNAs as Developmental Regulators. , 2015, Cold Spring Harbor perspectives in biology.

[73]  F. Lecoquierre,et al.  Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants , 2019, Genetics in Medicine.

[74]  L. Vissers,et al.  Detection of clinically relevant copy-number variants by exome sequencing in a large cohort of genetic disorders , 2016, Genetics in Medicine.

[75]  M. Gajecka.  Unrevealed mosaicism in the next-generation sequencing era , 2015, Molecular Genetics and Genomics.

[76]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[77]  Rolf Schröder,et al.  Clinical exome sequencing: results from 2819 samples reflecting 1000 families , 2016, European Journal of Human Genetics.

[78]  Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome , 2019, Nature Genetics.

[79]  Funded Statistical Methods groups-AWG,et al.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2017 .

[80]  Gert Jan van der Wilt,et al.  A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology , 2017, Genetics in Medicine.

[81]  Sarah E. Gould,et al.  Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts , 2019, Nature Medicine.

[82]  Zornitza Stark,et al.  Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases , 2018, npj Genomic Medicine.

[83]  Andrew R. Webster,et al.  Complex structural variants in Mendelian disorders: identification and breakpoint resolution using short- and long-read genome sequencing , 2018, Genome Medicine.

[84]  Chad A Shaw,et al.  Molecular Diagnostic Experience of Whole-Exome Sequencing in Adult Patients , 2015, Genetics in Medicine.

[85]  Anna Murray,et al.  Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis , 2013, Nature Genetics.

[86]  Kevin Y. Yip,et al.  Genome-Wide Structural Variation Detection by Genome Mapping on Nanochannel Arrays , 2015, Genetics.

[87]  G. Vriend,et al.  Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes. , 2017, American journal of human genetics.

[88]  Audrey Y. Chu,et al.  Epigenome-wide association studies identify DNA methylation associated with kidney function , 2017, Nature Communications.

[89]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[90]  Hugh E. Olsen,et al.  Nanopore long-read RNAseq reveals widespread transcriptional variation among the surface receptors of individual B cells , 2017, Nature Communications.

[91]  Tatsuhiko Tsunoda,et al.  Performance comparison of four commercial human whole-exome capture platforms , 2015, Scientific Reports.

[92]  Konrad J. Karczewski,et al.  Integrative omics for health and disease , 2018, Nature Reviews Genetics.